期刊文献+

黄芪苷对丙型肝炎病毒的抑制作用 被引量:2

Inhibitory effect of Astragalin on hepatitis C virus
原文传递
导出
摘要 目的研究黄芪苷对丙型肝炎病毒(HCV)的抑制作用。方法 MTT法检测不同浓度黄芪苷对Huh7.5.1细胞的抑制作用;间接免疫荧光试验检测不同浓度的黄芪苷、利巴韦林和干扰素(IFN)的抗HCV效果;Western blot法检测不同浓度黄芪苷、利巴韦林、IFN作用的Huh7.5.1细胞中HCV NS5A蛋白的表达情况。结果不同浓度黄芪苷对Huh7.5.1细胞的抑制率不同,并呈剂量依赖性。在最佳细胞密度1×10~4个/孔、最适MOI为1的条件下进行试验,利巴韦林对细胞的毒性呈剂量依赖性;IFN无明显的细胞毒性,其抗病毒滴度为7×10^(1.77) PFU/ml;黄芪苷的细胞毒性较小,其抗病毒滴度为7×10^(3.67) PFU/ml。黄芪苷能降低NS5A蛋白的表达,且随浓度增加抑制作用越明显。结论黄芪苷具有抗HCV的能力,其作用机制是通过抑制NS5A来实现的。 Objective To investigate the inhibitory effect of Astragalin on hepatitis C virus(HCV). Methods The inhibitory effect of Astragalin at various concentrations on Huh7. 5. 1 cells was determined by MTT assay, while that of various concentrations of Astragalin, ribavirin and interferon(IFN) on HCV by IFA. The expressions of HCV NS5 A protein in Huh7. 5. 1 cells treated with various concentrations of Asragalin, ribavirin and IFN were determined by Western blot. Results Astragalin showed dose-dependent inhibitory effect on Huh7. 5. 1 cells. Ribavirin showed dose-dependent toxicity to the cells at optimal density of 1 × 10~4 cells per well and optimal MOI of 1. IFN showed no significant cytotoxicity, of which antiviral titer was 7 × 10^(1.77)PFU/ml. Astragalin showed low cytotoxicity, of which the antiviral titer was 7 × 10^(3.67)PFU/ml. Astraglain decreased the expression of NS5 A, of which the inhibitory effect was dose-dependent.Conclusion Astragalin showed inhibitory effect on HCV by a mechanism of inhibiting NS5A.
作者 罗宏伟 李焱 LUO Hong-wei LI Yan(Tangshan Contagious Hospital, Tangshan 063000, Hebei Province, Chin)
出处 《中国生物制品学杂志》 CAS CSCD 2017年第6期623-627,共5页 Chinese Journal of Biologicals
关键词 黄芪苷 丙型肝炎病毒 抑制作用 Astragalin Hepatitis C virus(HCV) Inhibitory effect
  • 相关文献

参考文献4

二级参考文献34

  • 1Yang JIAO,Chun-min GE,Qing-hui MENG,Jian-ping CAO,Jian TONG,Sai-jun FAN.Dihydroartemisinin is an inhibitor of ovarian cancer cell growth[J].Acta Pharmacologica Sinica,2007,28(7):1045-1056. 被引量:40
  • 2Efferth T. Willmar Schwabe Award 2006: antiplasmodial and an- titumor activity of artemisinin-from bench to bedside [ J ]. Planta Med, 2007, 73(4) :299-309.
  • 3Lu JJ, Meng LH, Cai YJ, Chen Q, Tong LJ, Lin LP, et al. Di- hydroartemisinin~ induces apoptosis in HL-60 leukemia cells de- pendent of iron and p38 mitogen-activated protein kinase activa- tion but independent of reactive oxygen species [J]. Cancer Biol Ther, 2008, 7 (7) : 1017-1023.
  • 4Lu JJ, Chen SM, Zhafig XW, Ding J, Meng LH. The anti-cancer activity of dihydroartemisinin is associated with induction of iron- dependent endoplasmic reticulum stress in colorectal carcinomaHCTII6 eells[J/OL]. Invest New Drugs, 2011, 29(6):1276- 1283.
  • 5Lu JJ, Meng LH, Shankavaram UT, Zhu CH, Tong LJ, Chen G, et al. Dihydroartemisinin accelerates c-MYC oncoprotein degrada- tion and induces apoptosis in c-MYC-over expressing tumor cells [J]. Biochem Pharmacol, 2010, 80(1 ):22-30.
  • 6Hou J, Wang D, Zhang R, Wang H. Experimental therapy of hepatoma with artemisinin and its derivatives: in vitro and in vivo activity, chemosensitization, and mechanisms of action [ J ~. Clin Cancer Res, 2008, 14(17):5519-5530.
  • 7Wang SJ, Gao Y, Chen H, Kong R, Jiang HC, Pan SH, et al. Dihydroartemisinin inactivates NF-kappaB and potentiates the an- ti-tumor effect of gemcitabine on pancreatic cancer both in vitro and in vivo[ J]. Cancer Lett, 2010, 293( 1 ) :99-108.
  • 8Lu YY, Chen TS, Qu JL, Pan WL, Sun L, Wei XB. Dihydroar- temisinin (DHA) induces caspase-3-dependent apoptosis in hu- man lung adenocarcinoma ASTC-a-1 cells [ J ]. J Biomed Sci, 2009, 16:16.
  • 9Disbrow GL, Baege AC, Kierpiec KA, Yuan H, Centeno JA, Thibodeaux CA, et al. Dihydroartemisinin is cytotoxic to papillo- mavirus-expressing epithelial cells in vitro and in vivo[ J]. Cancer Res, 2005, 65 (23) : 10854-10861.
  • 10Chen HH, Zhou H J, Fang X. Inhibition of human cancer cell line growth and human umbilical vein endothelial cell angiogene- sis by artemisinin derivatives in vitro [ J ]. Pharmacol Res, 2003,48(3) :231-236.

共引文献76

同被引文献48

引证文献2

二级引证文献265

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部